J&J defeats generic drugmakers in US appeal over schizophrenia treatment – Reuters

Written by

admin

in

  1. J&J defeats generic drugmakers in US appeal over schizophrenia treatment  Reuters
  2. CAFC Upholds Win for Janssen on Patent for Antipsychotic Med Dosing Regimen  IPWatchdog.com
  3. J&J’s Invega Sustenna Patent Survives Teva, Viatris Appeals  Bloomberg Law News
  4. Full Fed. Circ. Rejects Mylan Rehearing Bid In Patent Case  Law360

Continue Reading

More posts